Olivia Buthman-Sinoy blasted two home runs and drove in five runs as Phillipsburg defeated Bernards 8-3 in Bernardsville. Buthman-Sinoy led the offensive charge, going 3-for-4. Her power display ...

Roche’s Genentech has inked a deal with Repertoire Immune Medicines aimed at discovering and developing T-cell-targeted medicines in the autoimmune disease space. Flagship Pioneering-backed ...

Genentech caved to President Trump's anti-DEI push. Now Roche is trying to get ahead of Trump's pressure, including with tariffs, to invest in the United States. Where big pharma fails, this ...

Using non-small cell lung cancer (NSCLC) as an example, PurpleLab and Genentech will explore how to leverage RWD to eliminate blind spots in the patient journey — informing every phase of a drug ...

Repertoire Immune Medicines Inc. has entered into a collaboration and license agreement with Genentech Inc., a member of the Roche Group, to discover and develop innovative T cell-targeted immune ...

PHILLIPSBURG, NJ - Freshman catcher Olivia Buthmann-Sinoy had the best day of her blossoming career with a pair of home runs and five RBI and senior third baseman Kayla Melsky kept up her hot ...

If you purchase a product or register for an account through a link on our site, we may receive compensation. By using this site, you consent to our User Agreement and agree that your clicks ...

Quita Highsmith is vice president and chief diversity officer at Genentech. From the San Francisco Business Times: Genentech Inc. is retreating from its broad, billion-dollar DEI goals amid ...

The games are getting more crucial as the softball regular season soon comes to a close. In important games, it’s often more experienced players who step up. That’s the case in this week’s ...

Aviv Regev, executive vice president and head of Genentech Research & Early Development (gRED) NVIDIA’s push into the life sciences sector has been rewarded by a wide-ranging deal with Roche’s ...

Since its peak in 1991, the cancer death rate has dropped 34%, averting an estimated 4.5 million deaths due, in part, to earlier detection of the most common types of cancer. Screening tests are ...

Ehrlich, who left Kodiak Sciences’ C-suite in August 2023, lists himself as CEO of a new ophthalmology biotech on LinkedIn and was global head of clinical ophthalmology at Genentech earlier in ...